CIK 0001099219 · Large accelerated filer
METLIFE INC
Sign in to watch- Ticker
- MET
- Exchange
- NYSE
- Industry
- Life Insurance
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 134075851
- Phone
- 212-578-5500
- Business address
- 200 PARK AVENUE, NEW YORK, NY, 10166
Securities
- MET Common Stock NYSE
- MET-PA Preferred Series A Floating Rate NYSE
- MET-PE Depositary Shares NYSE
- MET-PF Depositary Shares, each representing a 1/1,000th interest in a share of 4.75% Non-Cumulative Preferred Stock, Series F NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,298,702
- in 1 filing
Net −$19,298,702. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-16 | HUBBARD ROBERT GLENN Director | Grant or award | +1,016 | $87.40 | $89K | 107,573 |
| 2026-06-16 | Kennard William E Director | Grant or award | +587 | $87.40 | $51K | 47,410 |
| 2026-06-09 | Mumenthaler Christian Stephane Director | Grant or award | +20 | $85.57 | $2K | 2,865 |
| 2026-06-09 | Hay Laura J Director | Grant or award | +39 | $85.57 | $3K | 5,731 |
| 2026-06-09 | MCKENZIE DIANA Director | Grant or award | +169 | $85.57 | $14K | 24,642 |
| 2026-06-09 | TADROS RAMY President, U.S. Business | Grant or award | +127 | $85.57 | $11K | 216,946 |
| 2026-06-09 | Johnson Jeh C. Director | Grant or award | +61 | $85.57 | $5K | 8,911 |
| 2026-06-09 | Harris Carla A Director | Grant or award | +42 | $85.57 | $4K | 10,528 |
| 2026-06-09 | Glaser Daniel S Director | Grant or award | +7 | $85.57 | $599 | 2,108 |
| 2026-06-09 | HUBBARD ROBERT GLENN Director | Grant or award | +678 | $85.57 | $58K | 106,557 |
| 2026-06-09 | Kennard William E Director | Grant or award | +322 | $85.57 | $28K | 46,823 |
| 2026-06-01 | DEBEL MARLENE EVP & Chief Risk Officer | Option exercise | +10,600 | $46.85 | $497K | 164,980 |
| 2026-06-01 | DEBEL MARLENE EVP & Chief Risk Officer | Option exercise | +10,712 | $45.50 | $487K | 175,692 |
| 2026-06-01 | DEBEL MARLENE EVP & Chief Risk Officer | Sale | −21,312 | $81.59 | $1.7M | 154,380 |
| 2026-06-01 | DEBEL MARLENE EVP & Chief Risk Officer | Option exercise · Employee Stock Options (right to buy) | −10,600 | 0 | ||
| 2026-06-01 | DEBEL MARLENE EVP & Chief Risk Officer | Option exercise · Employee Stock Options (right to buy) | −10,712 | 0 | ||
| 2026-04-30 | O'Neill Adrienne Karen EVP & Chief Accounting Officer | Grant or award | +12,485 | 27,042 | ||
| 2026-04-01 | Mumenthaler Christian Stephane Director | Grant or award | +721 | $71.17 | $51K | 2,846 |
| 2026-04-01 | Hay Laura J Director | Grant or award | +721 | $71.17 | $51K | 5,692 |
| 2026-04-01 | Seitz Michelle Director | Grant or award | +721 | 994 |
Page 3 of 7 · 125 trades